Columbia University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).

958 total trials 171 currently recruiting 597 completed early-phase tilt top decile by trial count

Columbia University: 958 sponsored US clinical trials, 171 recruiting.

Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.

Top-decile sponsor footprint

Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 42/100

597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

958 total, page 11 of 20

COMPLETED NA

Holter Versus Zio Patch Electrocardiographic Monitoring in Children

NCT03309956

COMPLETED NA

Metabolism and Bariatric Surgery Study

NCT03371368

COMPLETED NA

Virtual Reality Mirror Therapy for Stroke

NCT03582397

COMPLETED NA

Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine

NCT03287830

COMPLETED NA

FluSAFE: Flu SMS Alerts to Freeze Exposure

NCT03274310

COMPLETED NA

Validation of the BREATHE Asthma Intervention Trial

NCT03300752

COMPLETED NA

Delayed Cord Clamping at Term Cesarean

NCT03150641

COMPLETED NA

Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD

NCT03203928

COMPLETED NA

Comparative Effectiveness of Stress Management

NCT03203902

COMPLETED NA

Acupuncture for Pain Management During Uterine Aspiration

NCT03391986

COMPLETED NA

Pilot Comparison of N-of-1 Trials of Light Therapy

NCT03167372

COMPLETED Early Phase 1

Endothelial Function in Obstructive Sleep Apnea

NCT03122639

COMPLETED NA

Encouraging LPG Adoption in Ghana: A Factorial Randomized Clinical Trial to Enhance LPG Adoption & Sustained Use

NCT03352830

TERMINATED Phase 2

TGR1202 in Relapsed and Refractory Follicular Lymphoma

NCT03178201

COMPLETED

Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy

NCT03225755

TERMINATED NA

Pharmacogenomic Testing in Major Depressive Disorder

NCT03228953

TERMINATED Phase 2

Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors

NCT02749227

COMPLETED Phase 4

PEMF and PEC Blocks in Mastectomy Reconstruction Patients

NCT03360214

TERMINATED Phase 2

Lung Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)

NCT02978144

TERMINATED Phase 2

Propranolol Dose Escalation in Lymphedema in Patients

NCT02595996

COMPLETED NA

Synchronized Immunization NotifiCations

NCT02710318

COMPLETED NA

Mechanical Environment Pregnancy With Short Cervix

NCT03865108

TERMINATED Phase 3

Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

NCT02850081

COMPLETED

Brain Vascular Disease in Aging and Dementia

NCT03075007

COMPLETED NA

Distraction for Reduction of Pain Associated With Venipuncture in the Pediatric Post-Transplant Population

NCT03004456

COMPLETED

Sleep Quality in High School Students With Asthma

NCT03073187

COMPLETED NA

Feasibility of the BREATHE Asthma Intervention Trial

NCT03036267

COMPLETED Phase 2

PREMIX vs PREMED Intranasal Lidocaine and Midazolam

NCT03054844

COMPLETED NA

Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients

NCT03203291

COMPLETED NA

Room to Grow Evaluation for Children

NCT04226053

COMPLETED NA

Assessing the Impact of an Educational HIV Prevention Intervention in Zambia

NCT03316040

COMPLETED Early Phase 1

Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study

NCT02783768

COMPLETED

Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer

NCT02948751

COMPLETED NA

BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs

NCT02796027

COMPLETED Phase 2

Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia

NCT02862210

COMPLETED NA

Comparison of Orbital Versus Rotational Atherectomy Effects On Coronary Microcirculation in PCI

NCT03021577

COMPLETED NA

Family Nurture Intervention in the NICU

NCT02710474

COMPLETED Early Phase 1

Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis

NCT03051646

COMPLETED

Medial Branch Radiofrequency Ablation and Lumbar Multifidi

NCT03744260

COMPLETED

Neuroimaging of Donor Iron Deficient Study

NCT02990559

COMPLETED

Microbiome of Donor Iron Deficient Study

NCT02990988

COMPLETED Phase 2

Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency

NCT03008915

COMPLETED NA

Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality

NCT02889133

TERMINATED NA

Mirror Therapy After Stroke: A Dosing Study

NCT02778087

COMPLETED NA

Effect of EITC on Biological Markers of Aging, Health and Mortality

NCT03226548

COMPLETED Phase 1

Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation

NCT02922127

COMPLETED NA

mVIP (Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV)

NCT02897141

COMPLETED NA

Platelet-rich Plasma in the Sacroiliac Joint

NCT03744234

COMPLETED

Treatment Patterns and Treatment Outcomes for Acromegaly

NCT03043586

COMPLETED NA

Efficacy of Vitamin D Supplementation in Obese Children

NCT02956408

← Previous Page 11 of 20 Next →

Phase Distribution

PhaseTrial count
Phase 1 86
Phase 2 105
Phase 3 23
Phase 4 65

What is open in the Columbia University pipeline

171 recruiting of 958 indexed (18% open); 597 completed (62%).

Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).

Top condition: Obesity (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Columbia University: open-pipeline peers nationwide

Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20% Total trials Recruiting share Columbia UniversityUniversity of MinnesotaBrigham and Women's HospitalHoffmann-La RocheUniversity of California, Los AngelesKite, A Gilead CompanyMirum PharmaceuticalsWest Virginia UniversityHospital for Special Surgery, New York
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 958 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this Columbia University page

958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.

  • 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Columbia University pipeline card: 958 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.